We have previously examined the expression of (H-ras) oncogene related transcripts (Spandidos and Agnantis: Anticancer Res 4: 269-272, 1984) and also the activation of the H-ras oncogene (Spandidos: Anticancer Res 7: 991-996, 1987) in human malignant breast cancers. Our results revealed overexpression of the H-ras transcripts in malignant compared to normal tissues, while in the same tumour specimens certain point mutations and other genetic changes have been found in the H-ras gene. In this paper we have investigated c-myc oncoprotein expression in the same tumour samples using an ELISA technique (Moore et al: Oncogene Res 2: 65-80, 1989). Elevated c-myc oncoprotein expression was found in all of the tumour specimens compared with normal breast tissues from a patient with no evidence of the disease. A correlation was found between T stage and c-myc expression in both the normal tissue from the resection margin and in the breast tumour specimens. However, no correlation was found between survival and elevated c-myc expression.

Download full-text PDF

Source

Publication Analysis

Top Keywords

tumour specimens
12
elisa technique
8
h-ras oncogene
8
anticancer res
8
compared normal
8
c-myc oncoprotein
8
oncoprotein expression
8
expression tumour
8
elevated c-myc
8
c-myc expression
8

Similar Publications

Micropapillary adenocarcinoma (MPC) is an aggressive histological subtype of lung adenocarcinoma (LUAD). MPC is composed of small clusters of cancer cells exhibiting inverted polarity. However, the mechanism underlying its formation is poorly understood.

View Article and Find Full Text PDF

D-loop mutations in mitochondrial DNA are a risk factor for chemotherapy resistance in esophageal cancer.

Sci Rep

December 2024

Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University, 2-2-E2, Yamada-Oka, Suita, Osaka, 565-0871, Japan.

Esophageal cancer is a highly aggressive disease, and acquired resistance to chemotherapy remains a significant hurdle in its treatment. mtDNA, crucial for cellular energy production, is prone to mutations at a higher rate than nuclear DNA. These mutations can accumulate and disrupt cellular function; however, mtDNA mutations induced by chemotherapy in esophageal cancer remain unexplored.

View Article and Find Full Text PDF

Circulating tumor DNA (ctDNA) can be used to assess treatment response in patients with undifferentiated pleomorphic sarcoma (UPS). The importance of this is explored in our case of a 75-year-old man who was diagnosed with UPS of the right kidney. After a right nephrectomy and tumor resection, the patient was recovering well with initially undetectable, and then slightly elevated, circulating tumor DNA.

View Article and Find Full Text PDF

Soft tissue and bone tumors are rare, and their low frequency and diverse histological types make conducting large-scale clinical trials challenging. Patient-derived xenografts (PDX), entailing implantation of cancer specimens in immunocompromised mice, are emerging as a valuable translational model because PDX keeps the original tumors' character and drug sensitivity. We sequentially transplanted 166 surgical and biopsy specimens from orthopedic surgeries, including 138 soft tissue and bone tumors (81 malignant, 23 intermediate, and 34 benign), 16 metastatic bone tumors, 9 hematological malignancies, and 3 non-tumor tissues.

View Article and Find Full Text PDF

Objective: Diagnosing neoplasms of the salivary gland is challenging, as morphologic features of these tumors are complex, and well-defined diagnostic categories have overlapping features. Many salivary gland neoplasms are associated with recurrent genetic alterations. The utilization of RNA-based targeted next-generation sequencing (NGS) panels for the detection of cancer-driving translocations and mutations is emerging in the clinical laboratory.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!